30 Oct 2019

3TR Kick-off meeting

COMBINE Group (University of Catania) is one of the partner of 3TR project, the largest-ever Innovative Medicine Initiative 2 (IMI2) immunology project to improve disease management of non-responders to therapy across seven immune-mediated diseases.

Read on: Full Description of 3TR and See the video